Related Experiment Video
Updated: Aug 8, 2026
07:43
Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons
Published on: January 7, 2019
Charcot-Marie-Tooth disease in children
Ezgi Saylam1, Praveen Kumar Ramani2, Ruthwik Duvuru2
1Division of Neurology Nationwide Children's Hospital Columbus Ohio USA.
Annals of the Child Neurology Society
|August 7, 2026
Summary
Charcot-Marie-Tooth (CMT) disease is a common inherited neuropathy affecting nerves and muscles. This review details pediatric CMT
Area of Science:
- Neurology
- Genetics
- Pediatrics
Background:
- Charcot-Marie-Tooth (CMT) disease is the most prevalent inherited neuropathy, affecting approximately 9.7 to 82 per 100,000 individuals.
- Despite its prevalence, CMT is underrepresented in genetic databases, highlighting a need for comprehensive documentation.
- CMT presents with progressive muscle weakness and atrophy, predominantly in distal extremities, alongside potential deformities and systemic issues.
Purpose of the Study:
- To provide a comprehensive review of pediatric Charcot-Marie-Tooth disease.
- To examine clinical features, subtypes, genetic factors, and pathomechanisms.
- To offer a resource for clinicians on diagnosing and managing CMT, emphasizing standardized approaches.
Main Methods:
- Review of existing literature on pediatric Charcot-Marie-Tooth disease.
- Analysis of clinical manifestations, genetic underpinnings, and pathomechanisms.
- Emphasis on diagnostic tools including family history, clinical evaluation, nerve conduction studies, and genetic testing.
Main Results:
- CMT diagnosis requires a multi-faceted approach, including detailed patient history and specialized tests.
- Differential diagnosis is critical to distinguish CMT from other neuropathies with similar symptoms.
- Advancements in genetic testing are crucial for identifying diverse CMT subtypes and informing management.
Conclusions:
- Accurate diagnosis and management of pediatric CMT necessitate a thorough understanding of its varied presentations and genetic basis.
- A standardized and streamlined diagnostic and management strategy is essential for effective patient care.
- Continued research into CMT subtypes and pathomechanisms will improve clinical outcomes.
Related Concept Videos
01:15Teeth
The formation of teeth, also known as odontogenesis, is a complex process that begins in utero, around the sixth week of embryonic development. There are three stages to this process: the bud stage, the cap stage, and the bell stage.
In the bud stage, the tooth germ (an aggregation of cells) starts to form in the developing jawbone. During the cap stage, the tooth germ differentiates into enamel organ, dental papilla, and dental sac, which will later develop into the tooth's enamel, dentin and...
In the bud stage, the tooth germ (an aggregation of cells) starts to form in the developing jawbone. During the cap stage, the tooth germ differentiates into enamel organ, dental papilla, and dental sac, which will later develop into the tooth's enamel, dentin and...
01:21Tooth Anatomy
The human tooth enables us to eat a variety of foods, speak clearly, and even aid in shaping our faces. Teeth are composed of various elements that work together. Here's a detailed look at the anatomy of a human tooth.
The Crown, Neck, and Root
The visible part of the tooth is referred to as the crown. It's covered by enamel, the hardest substance in the human body. The crown is uniquely shaped for each type of tooth, allowing for different functions such as cutting, tearing, or grinding food.
The Crown, Neck, and Root
The visible part of the tooth is referred to as the crown. It's covered by enamel, the hardest substance in the human body. The crown is uniquely shaped for each type of tooth, allowing for different functions such as cutting, tearing, or grinding food.
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
01:23Cystic Fibrosis: Pathogenesis
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
01:29Bone Disorders
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
01:24Cystic Fibrosis: Management
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Sinus disease and chronic sinusitis...